CORRESP Filing
GRI Bio, Inc.
Date: Jan. 30, 2026 · CIK: 0001824293 · Accession: 0001824293-26-000036
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293065
Letter
Document GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA, CA 92037 January 30, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards Re: GRI Bio, Inc. Registration Statement on Form S-3 Filed January 30, 2026 File No. 333-293065 (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, GRI Bio, Inc. (the “Registrant”) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, January 30, 2026, at 4:05 p.m., Eastern Time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Melanie Ruthrauff Levy or Jessica Zhang of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 or (415) 432-6119, respectively, with any questions regarding this request. Very truly yours, GRI BIO, INC. /s/ W. Marc Hertz, Ph.D. W. Marc Hertz, Ph.D., Chief Executive Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C . Adam Lenain, Esq. Melanie Ruthrauff Levy, Esq. Jessica Zhang, Esq.
Show Raw Text
CORRESP 1 filename1.htm Document GRI BIO, INC. 2223 AVENIDA DE LA PLAYA, SUITE 208 LA JOLLA, CA 92037 January 30, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards Re: GRI Bio, Inc. Registration Statement on Form S-3 Filed January 30, 2026 File No. 333-293065 (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, GRI Bio, Inc. (the “Registrant”) hereby respectfully requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Friday, January 30, 2026, at 4:05 p.m., Eastern Time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Melanie Ruthrauff Levy or Jessica Zhang of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (858) 314-1873 or (415) 432-6119, respectively, with any questions regarding this request. Very truly yours, GRI BIO, INC. /s/ W. Marc Hertz, Ph.D. W. Marc Hertz, Ph.D., Chief Executive Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C . Adam Lenain, Esq. Melanie Ruthrauff Levy, Esq. Jessica Zhang, Esq.